Strategies to Reduce HCV Incidence in Key Populations: The Role of HCV Treatment as Prevention

Tailored for clinicians practicing in the European Union this program equips participants with key strategies for effectively curing HCV in critical transmitting populations such as PWID and incarcerated individuals.

Share

Program Content

Activities

Implementing HCV TasP in Europe
Expert Perspective on Implementing HCV Treatment as Prevention in At-Risk European Populations
Congratulations: You achieved a completion on 04/09/2022
Downloadable Slideset
Strategies to Reduce HCV Incidence in At-Risk European Populations
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 27, 2019

Expires: March 25, 2020

Activities

HCV TasP in France
Lessons From France on Implementing HCV Treatment as Prevention: Whom Should We Treat and How?
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 23, 2019

Expires: April 21, 2020

HCV TasP in Germany
Applying HCV Treatment as Prevention in Germany: Successes and Ongoing Challenges
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 17, 2019

Expires: May 15, 2020

HCV Elimination in Spain
HCV Elimination in Spain: Overcoming Challenges in High-Risk Populations
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 05, 2019

Expires: July 03, 2020

HCV TasP in Italy
HCV Treatment as Prevention in Italy: Overcoming Regulatory Barriers
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 02, 2019

Expires: July 31, 2020

HCV TasP in Scotland
Collecting Real-World Data on HCV Treatment as Prevention in PWID: The Scottish Experience
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 04, 2019

Expires: September 02, 2020

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Gilead

Partners

INHSU

ProCE Banner